FDA, DEA Blame Demand, Drug Makers for ADHD Med Shortage
In a letter to the public the FDA and the DEA contend that unprecedented demand, potential overprescribing, and underproduction are the primary reasons for the national shortage of stimulants to treat ADHD.
Medscape Medical News
source https://www.medscape.com/viewarticle/995079?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/995079?src=rss
Comments
Post a Comment